Sponsorsview all sponsors
MSHO continuously contacts legislators, provides comments to policy makers and collaborates with payers on issues of concern to those delivering care to cancer patients.
It is important that our members are aware of meetings, web casts, and other educational opportunities specifically designed to address the complexities of cancer care.
NEW Use for ALIMTA (pemetrexed for injection)
FDA approves NEW use of ALIMTA (pemetrexed for injection) in the Continuation Maintenance Setting for Advanced Nonsquamous Non-Small Cell Lung Cancer READ MORE